Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

33.86
-0.3088-0.90%
Post-market: 33.860.00000.00%16:10 EDT
Volume:5K
Turnover:153.07K
Market Cap:13.54M
PE:- -
High:34.24
Open:34.24
Low:33.86
Close:34.17
52wk High:34.86
52wk Low:25.79
Shares:400.00K
Float Shares:400.00K
Volume Ratio:7.80
T/O Rate:1.13%
Dividend:0.08
Dividend Rate:0.24%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Apollo in Advanced Talks to Acquire Johnson \u0026 Johnson's Orthopedics Unit in Deal Valued Near $20B

Stock News
·
Sep 12

Edwards Lifesciences CVP, TAVR Daniel J. Lippis Disposes of 619 Common Shares Worth $54,168.69

Reuters
·
Sep 12

J&J Orthopedics Unit Draws Apollo Interest in Potential $20 Billion Deal, Bloomberg News Reports

Reuters
·
Sep 12

Apollo Global is Said in Talks to Acquire J&J’s Orthopedics Unit - Bloomberg News

THOMSON REUTERS
·
Sep 12

Scholar Rock announces FDA approval of isembyld

TIPRANKS
·
Sep 12

US FDA Approves Scholar Rock's Muscle Weakness Drug

Reuters
·
Sep 12

Edwards Lifesciences Corp. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 12

Moderna Inc. Stock Rallies 5.4%, Outperforms Peers

Dow Jones
·
Sep 12

IntegraGen receives rival takeover bids amid court‑ordered restructuring

TIPRANKS
·
Sep 12

Pharming wins FDA nod to extend Joenja use to younger APDS children

TIPRANKS
·
Sep 12

DBS Keeps Their Buy Rating on Merck & Company (MRK)

TIPRANKS
·
Sep 12

Tylenol Maker, Pharmacy Chains Urge US Appeals Court to Revisit Decision over Alleged Autism Link

Reuters
·
Sep 12

Berenberg Lifts Price Target on Merck to $137 From $127, Keeps Hold Rating

MT Newswires Live
·
Sep 11

Edwards Lifesciences Price Target Maintained with a $110.00/Share by BTIG

Dow Jones
·
Sep 11

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Labcorp Holdings (LH) and Edwards Lifesciences (EW)

TIPRANKS
·
Sep 11

Edwards Lifesciences Reaffirms 2026 Guidance Following Medicare TAVR Decision

MT Newswires Live
·
Sep 11

Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Merck & Company (MRK) and Pacific Biosciences (PACB)

TIPRANKS
·
Sep 11

Shenyang Xingqi Gains Nod for Eye Drop Candidate Clinical Study

Stock News
·
Sep 11

The Race for the Next Big Weight-Loss Drug is On-and China Wants In

Dow Jones
·
Sep 11

Edwards Lifesciences comments on TAVR national coverage decision

TIPRANKS
·
Sep 11